Allison Wey | VP of IR and Corporate Communications |
Jay Hagan | President and CEO |
Tim Wright | Chief R&D Officer |
Dan Chevallard | CFO |
Liana Moussatos | Wedbush Securities |
Eric Smith | Cowen and Company |
Alan Carr | Needham and Company |
Matthew Luchini | BMO Capital |
Good afternoon ladies and gentlemen, and thank you for standing by. Welcome to Regulus Therapeutics Fourth Quarter 2017 Conference Call. [Operator Instructions] And as a reminder, this conference is being recorded.
Now I’d like to welcome and turn the call to Ms. Allison Wey, Vice President of Investor Relations and Corporate Communications.